文献检索
文档翻译
深度研究
Zotero 插件
邀请有礼
套餐&价格
历史记录
Suppr
超能文献
应用&插件
No compelling reason to adopt new antivirals whenever it is reasonable to wait.
出版信息
Prescrire Int. 2015 Jan;24(156):8.
PMID:
25729821
Abstract
摘要
文献AI研究员
20分钟写一篇综述,助力文献阅读效率提升50倍。
立即体验
用中文搜PubMed
大模型驱动的PubMed中文搜索引擎
马上搜索
文档翻译
学术文献翻译模型,支持多种主流文档格式。
立即体验
应用&插件
Zotero 插件
浏览器插件
Mac 客户端
Windows 客户端
微信小程序
定价
高级版会员
购买积分包
购买API积分包
服务
文献检索
文档翻译
深度研究
API 文档
关于我们
关于 Suppr
公司介绍
联系我们
用户协议
隐私条款
关注我们
Suppr 超能文献
核心技术专利:
CN118964589B
侵权必究
粤ICP备2023148730 号-1
Suppr @ 2025
相似文献
1
No compelling reason to adopt new antivirals whenever it is reasonable to wait.
Prescrire Int. 2015 Jan;24(156):8.
2
Sofosbuvir (Sovaldi°). Active against hepatitis C virus, but evaluation is incomplete .
Prescrire Int. 2015 Jan;24(156):5-10.
3
Treatment of chronic hepatitis C virus infection in the near future.
Ann Hepatol. 2013 Nov-Dec;12(6):854-9.
4
A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection.
Eur J Gastroenterol Hepatol. 2019 Mar;31(3):382-388. doi: 10.1097/MEG.0000000000001299.
5
HCV treatment--no more room for interferonologists?
N Engl J Med. 2013 May 16;368(20):1931-2. doi: 10.1056/NEJMe1303818. Epub 2013 Apr 23.
6
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.
N Engl J Med. 2014 Jan 16;370(3):211-21. doi: 10.1056/NEJMoa1306218.
7
Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy.
J Hepatol. 2014 Aug;61(2):435-8. doi: 10.1016/j.jhep.2014.04.042. Epub 2014 May 6.
8
Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.
Pediatr Infect Dis J. 2016 Dec;35(12):1373. doi: 10.1097/INF.0000000000001336.
9
Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection.
Aliment Pharmacol Ther. 2014 Mar;39(5):478-87. doi: 10.1111/apt.12601. Epub 2014 Jan 6.
10
Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection.
Gastroenterology. 2014 Mar;146(3):736-743.e1. doi: 10.1053/j.gastro.2013.11.007. Epub 2013 Nov 18.